[Other] Screening for Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Evidence, Challenges, and the Role of Imaging—From theAJRSpecial Series on Screening |
|
This post will be closed automatically in 2026-09-24 22:08
Reward20points
|